 CINCINNATI, Jan. 4, 2022 PRNewswire -- Meridian Bioscience, Inc. NASDAQ: VIVO a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the 2022 H. C. Wainwright Bioconnect Virtual Conference. 